BioSpace News Archive

The U.S. Food and Drug Administration and the Federal Trade Commission today signed a joint statement regarding enhanced collaboration in support of a robust marketplace for biological products, including the critical adoption of biosimilars and interchangeable products.

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today, that it has filed a registration statement on Form F-1 with the United States Securities and Exchange Commission (the “SEC”) to offer 6,000,000 American Depositary Shares (“ADSs”) representing its ordinary shares.

AdvanSource Biomaterials Corporation announced that on Friday, January 31, 2020, substantially all of its assets were sold to Mitsubishi Chemical Performance Polymers, Inc.

Catalent, Inc. announced the pricing of an underwritten public offering of shares of its common stock, which is expected to result in gross proceeds of approximately $500 million, before deducting estimated offering expenses.

CELLINK, focused on the commercialization of innovative technologies for bioprinting and associated technologies for preparation and analysis of 3D-bioprinted tissues, announced today that the company has renewed its agreement to collaborate with the global biopharmaceutical company AstraZeneca for an additional 12 months.

PharmaCord, LLC, a rapidly growing provider of patient services to life sciences companies, announced today that it has commenced a partnership with Surescripts, the nation’s leading health information network, to expedite patient access to specialty medications and enhance the overall experience of therapy.

Esperion (NASDAQ: ESPR) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the MAA for the bempedoic acid / ezetimibe fixed dose combination tablet, recommending approval for the treatment of hypercholesterolemia and mixed dyslipidemia.

China Jo-Jo Drugstores, Inc. announced that the Company has pledged to provide assistance to those affected by the contagious virus and fight against the 2019 Novel Coronavirus, or coronavirus[1] outbreak in Hangzhou, China, where the Company is headquartered.

Neurocrine Biosciences, Inc. announced the appointment of Shalini Sharp to its Board of Directors.